Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

The PLOS ONE Staff

doi:10.1371/journal.pone.0111690

. 2014 Oct 17;9(10):e111690. doi: 10.1371/journal.pone.0111690

Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

The PLOS ONE Staff

PMCID: PMC4201575

The affiliation for the fourth author is incorrect. Marilyn J. Telen is not affiliated with #6 but with Duke University Medical Centre, Durham, North Carolina, United States of America.

Reference

1. Wun T, Styles L, DeCastro L, Telen MJ, Kuypers F, et al. (2014) Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia. PLoS ONE 9(7): e101301 doi:10.1371/journal.pone.0101301 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0111690-Wun1] 1. Wun T, Styles L, DeCastro L, Telen MJ, Kuypers F, et al. (2014) Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia. PLoS ONE 9(7): e101301 doi:10.1371/journal.pone.0101301 [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

Reference

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

Reference

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases